| Literature DB >> 36005932 |
Elizabeth A Hall1, Madison B Roberts1, Katharyn A Taylor1, Dawn E Havrda1.
Abstract
Remote proctoring is often used to ensure testing integrity in a distance education environment but may impact academic performance. This quasi-experimental study aimed to evaluate changes in examination scores after transitioning to remote proctoring during the COVID-19 pandemic. Student pharmacists (n = 384) served as their own controls in this before-after analysis of examination scores with in-person versus remote proctoring. To assess differences in examination scores among students with varying levels of testing anxiety, students were classified into low, moderate, or high testing anxiety groups based on their Cognitive Test Anxiety Scale-Second Edition (CTAS-2) score. Students were also stratified into two groups based on their cumulative grade point average (GPA). After transitioning to remote proctoring, examination scores significantly decreased for first-year (P1) students but significantly increased for second-year (P2) students. When stratified by CTAS-2 score, no significant difference in examination scores was found. When stratified by GPA, no significant difference in examination scores was found for P1 students, but a significant improvement was noted for P2 students with remote proctoring. The results of this study indicate that examination scores do not consistently improve or decline after introducing remote proctoring even when considering a student's GPA and level of testing anxiety.Entities:
Keywords: COVID-19; academic performance; assessment; proctoring; testing anxiety
Year: 2022 PMID: 36005932 PMCID: PMC9416767 DOI: 10.3390/pharmacy10040092
Source DB: PubMed Journal: Pharmacy (Basel) ISSN: 2226-4787
Composite examination structure and proctoring modality.
| Composite Examination with In-Person Proctoring | Composite Examination with Remote Proctoring | |||||||
|---|---|---|---|---|---|---|---|---|
| Year | Course | 1 | 2 | 3 | 4 | 6 | 7 | 8 |
| No. of Questions | ||||||||
| P1 | Cardiology | 40 | 52 | 36 | 44 | 42 | 32 | 35 |
| D4 | 16 | 12 | 16 | 16 | 12 | 12 | 0 | |
| PK | 20 | 20 | 19 | 23 | 20 | 24 | 20 | |
|
|
|
|
|
|
|
|
| |
| P2 | LESD | 8 | 16 | 16 | 16 | 16 | 16 | 0 |
| ID | 64 | 48 | 56 | 52 | 0 | 0 | 0 | |
| SCCT | 0 | 0 | 0 | 0 | 44 | 52 | 48 | |
|
|
|
|
|
|
|
|
| |
D4, drug dosage, design, and delivery; ID, infectious diseases; LESD, literature evaluation and study design; P1, first-year student pharmacist; P2, second-year student pharmacist; PK, pharmacokinetics; SCCT, surgery, critical care, and transplant.
Participant demographic characteristics.
| P1 Students ( | P2 Students ( | |
|---|---|---|
| Age, mean (SD) | 24.6 (4.09) | 24.8 (2.93) |
| Gender, n (%) | ||
| Female | 125 (65.8) | 116 (59.8) |
| Male | 65 (34.2) | 78 (40.2) |
| Race, n (%) | ||
| White | 119 (62.6) | 136 (70.1) |
| Minority | 69 (36.3) | 53 (27.3) |
| Not reported | 2 (1.1) | 5 (2.6) |
| GPA, mean (SD) | 3.25 (0.48) | 3.15 (0.52) |
| CTAS-2, mean (SD) | 52.6 (15.9) | 50.4 (16.5) |
CTAS-2, Cognitive Test Anxiety Scale—Second Edition; GPA, grade point average; P1, first-year student pharmacist; P2, second-year student pharmacist.
Figure 1Comparison of spring 2020 composite examination scores for first-year (P1) and second-year (P2) student pharmacists with in-person versus remote proctoring.
Figure 2Change in examination performance after the transition to remote proctoring stratified by severity of student testing anxiety as determined by CTAS-2 score.
Figure 3Change in examination performance after the transition to remote proctoring, stratified by student GPA.